Rithm Capital Corp.

▲ Bull Case

• ◆Earnings inflection sustains and compounds. FY2026E EAD of $2.00 grows to $2.70 by FY2030 through Newrez cycle recovery, full-year Sculptor + Crestline contribution, and Elecor stabilization. Internalized management drives re-rating from 4.7× P/EAD trough to 9-11× — the multiple for diversified financial hybrids like PFSI/PMT.
• ◆Asset-management franchise crosses credibility threshold. Sculptor + Crestline combined AUM grows from ~$60B to $75-90B by FY2028 through real-estate-debt and private-credit fundraising. At alt-manager peer multiples (12-18× management fees), this segment alone could be worth $3-5B — half of current market cap. Catalyst: 2-3 consecutive quarters of net inflows forcing split-valuation.
• ◆Sum-of-the-parts dwarfs consolidated price. Conservative SOTP (35% discount) yields ~$14.80/share; bull SOTP (15% discount) yields ~$19.40/share. A partial Newrez IPO (repeatedly mentioned by management) would crystallize the discount and force analyst re-valuation.

▼ Bear Case

• ◆Aggressive Fed easing triggers MSR-portfolio collapse. If Fed cuts to 2.5% within 18 months, prepayment speeds accelerate on locked-in 3% vintage. MSR fair value drops 15-20% (-$1.6 to -$2.2B), book value falls to ~$10.50-11.00, and dividend coverage tightens. Newrez origination surge only offsets 50-70% of the MSR loss.
• ◆Elecor becomes balance-sheet anchor, not opportunity. Class A NYC/SF office market remains depressed; Elecor net contribution stays at $0-50M annually instead of ramping to $170M. Impairment charge of $400-850M by FY2028 drags BVPS CAGR from 9% to 5% and casts doubt on management's capital-allocation judgment.
• ◆Sculptor and Crestline integration produces AUM attrition, not growth. Institutional LPs view RITM-ownership as compromising independence. Net redemptions of 15-25% reduce AUM to ~$45-50B; management fee revenue compresses by $100-150M. The re-rating thesis collapses entirely.

“The Street is debating whether the FY2026 EAD inflection is sustainable or a cyclical peak. Bulls see Q1 2026 ($0.51 EAD/share, $2.04 annualized) as proof of structural earnings power post-internalization and Sculptor/Crestline integration. Bears worry Q1 strength reflects one-time Crestline accruals, origination front-loading, and high incentive-fee crystallization that won't repeat. Secondarily, the Street debates whether RITM is too diversified to be valued cleanly. Bulls argue the conglomerate structure creates SOTP-discount opportunities and internalization + Newrez IPO will unlock value progressively. Bears worry it has created an unfocused 'financial conglomerate' earning a structural discount like GE-era conglomerates. Consensus has resolved this debate cautiously bullish: 8 analysts at Strong Buy, $14.56 average target, $13.50-$16.00 range.”

• ◆Q2 + Q3 2026 EAD prints confirming $2.00+ annualized run-rate — validates FY26 inflection thesis
• ◆Sculptor + Crestline net AUM inflows — first credible signal that platform is gaining institutional traction
• ◆Newrez IPO or partial sale announcement — would crystallize the SOTP discount
• ◆Bulk MSR acquisition of $50-100B UPB block — banks remain motivated sellers under capital pressure
• ◆Elecor leasing/occupancy update — first major operational data point on the office portfolio
• ◆Dividend stability commentary at any earnings call — particularly under rate-easing scenarios
• ◆Internalization 'second-act' governance reforms — proxy proposals, board changes, comp restructuring
• ◆Resumption of buybacks at sub-0.85× book — direct accretion mechanism at current levels

• ◆Aggressive Fed easing (Funds to <3%) triggering MSR markdown — single highest-impact rate risk; -$2/share BVPS potential
• ◆Office sector worsening forcing Elecor impairment — $400-850M potential GAAP loss
• ◆Sculptor / Crestline AUM attrition >15% — invalidates AM re-rating thesis entirely
• ◆Credit cycle break (delinquencies >5%) — servicer advance funding stress; potential liquidity event
• ◆Dividend cut — would be sentiment-destroying even if economically defensible
• ◆Repo market disruption (March 2020-style) — forced asset sales at distressed prices
• ◆CFPB or state regulatory action against Newrez — operational and reputational damage
• ◆Capital raise dilution — RITM has demonstrated acquisition appetite; bear case includes ~$1B raise at $7-8